SCHEMBL9289885

SCHEMBL9289885

CCN1C(=O)/C(=C2\SCCN2CC)SC1=S

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 12/20 0.55
▸ MEN1 O00255 11/20 0.55
▸ ALDH1A1 P00352 10/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ GAA P10253 2/20 0.55
▸ HCRTR1 O43613 1/20 0.55
▸ CASP1 P29466 1/20 0.55
▸ BRCA1 P38398 1/20 0.55
▸ MAPT P10636 8/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ TNNI3 P19429 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ TNNT2 P45379 1/20 0.48
▸ TNNC1 P63316 1/20 0.48
▸ MAPK1 P28482 5/20 0.44
▸ MMP13 P45452 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9413626 0.85 MEN1 (0.58) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL9858007 0.85 MEN1 (0.58) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL9857493 0.76 MEN1 (0.54) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL12194178 0.76 KMT2A (0.57) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL12194186 0.76 ALDH1A1 (0.50) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL10036031 0.73 ALDH1A1 (0.76) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL10713273 0.73 ALDH1A1 (0.76) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL12459416 0.70 KMT2A (0.50) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL14273144 0.69 KMT2A (0.60) KMT2AMEN1ALDH1A1HSD17B10GAA
SCHEMBL12218400 0.69 KMT2A (0.55) KMT2AMEN1ALDH1A1HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9574060-B2 Antimicrobial housing and cover for a medical device BAXTER INTERNATIONAL INC. (US) 2017-02-21 — — US disclosed
US-9574060-B2 Antimicrobial housing and cover for a medical device BAXTER INTERNATIONAL INC. (US) 2017-02-21 — — US disclosed
EP-2057275-B1 ARRAY FOR RAPID DETECTION OF A MICROORGANISM KIMBERLY CLARK CO (US) 2017-02-01 — — EP disclosed
EP-1919421-B1 SOLVATOCHROMIC VISUAL INDICATOR AND THE USE OF THE SAME KIMBERLY CLARK CO (US) 2016-06-08 — — EP disclosed
EP-2238259-B1 OPTICAL INDICATOR FOR DETECTING BACTERIAL PATHOGENS KIMBERLY CLARK CO (US) 2016-03-23 — — EP disclosed
US-20150322229-A1 ANTIMICROBIAL HOUSING AND COVER FOR A MEDICAL DEVICE BAXTER INTERNATIONAL INC. 2015-11-12 — — US disclosed
US-20150322229-A1 ANTIMICROBIAL HOUSING AND COVER FOR A MEDICAL DEVICE BAXTER INTERNATIONAL INC. 2015-11-12 — — US disclosed
EP-1694857-B1 MICROBIAL DETECTION AND QUANTIFICATION KIMBERLY CLARK CO (US) 2015-11-11 — — EP disclosed
US-9125973-B2 Antimicrobial housing and cover for a medical device BAXTER INTERNATIONAL INC. (US) 2015-09-08 — — US disclosed
US-9125973-B2 Antimicrobial housing and cover for a medical device BAXTER INTERNATIONAL INC. (US) 2015-09-08 — — US disclosed
WO-2008026104-A2 ARRAY FOR RAPID DETECTION OF A MICROORGANISM KIMBERLY-CLARK WORLDWIDE, INC. (US) 2008-03-06 — — WO disclosed
US-7300770-B2 Detection of microbe contamination on elastomeric articles KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-11-27 — — US disclosed
US-7300770-B2 Detection of microbe contamination on elastomeric articles KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-11-27 — — US disclosed
US-20070249012-A1 Microbial Detection and Quantification KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-10-25 — — US disclosed
US-20070249012-A1 Microbial Detection and Quantification KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-10-25 — — US disclosed
US-20070140971-A1 Method for screening for bacterial conjunctivitis KIMBERLY-CLARK WORLDWIDE, INC. 2007-06-21 — — US disclosed
US-20070140971-A1 Method for screening for bacterial conjunctivitis KIMBERLY-CLARK WORLDWIDE, INC. 2007-06-21 — — US disclosed
WO-2007027899-A1 SOLVATOCHROMIC VISUAL INDICATOR AND THE USE OF THE SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-03-08 — — WO disclosed
US-20070048503-A1 graphic and/or message display system has a hidden graphic or message on an indicator panel; revealed when an obscuring graphic reacts with a solvent to change color; use on products to alert the wearer KIMBERLY-CLARK WORLDWIDE, INC. 2007-03-01 — — US disclosed
US-20070048503-A1 graphic and/or message display system has a hidden graphic or message on an indicator panel; revealed when an obscuring graphic reacts with a solvent to change color; use on products to alert the wearer KIMBERLY-CLARK WORLDWIDE, INC. 2007-03-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070140971-A1 Method for screening for bacterial conjunctivitis TLR8, TLR3, TLR4 KMT2A 3821/4885MEN1 2174/4885ALDH1A1 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback